-
1
-
-
84896055390
-
Meta-analysis of risk of stroke or transient ischemic attack with dabigatran for atrial fibrillation ablation
-
S. Sardar, R. Nairooz, S. Chatterjee, J. Wetterslev, J. Ghosh, and W.S. Aronow Meta-analysis of risk of stroke or transient ischemic attack with dabigatran for atrial fibrillation ablation Am J Cardiol 113 2014 1173 1177
-
(2014)
Am J Cardiol
, vol.113
, pp. 1173-1177
-
-
Sardar, S.1
Nairooz, R.2
Chatterjee, S.3
Wetterslev, J.4
Ghosh, J.5
Aronow, W.S.6
-
2
-
-
84885002072
-
Safety and efficacy of dabigatran etexilate during catheter ablation of atrial fibrillation: a meta-analysis of the literature
-
S.H. Hohnloser, and A.J. Camm Safety and efficacy of dabigatran etexilate during catheter ablation of atrial fibrillation: a meta-analysis of the literature Europace 15 2013 1407 1411
-
(2013)
Europace
, vol.15
, pp. 1407-1411
-
-
Hohnloser, S.H.1
Camm, A.J.2
-
3
-
-
84897449184
-
Safety of short-term use of dabigatran or rivaroxaban for direct-current cardioversion in patients with atrial fibrillation and atrial flutter
-
A. Yadlapati, C. Groh, and R. Passman Safety of short-term use of dabigatran or rivaroxaban for direct-current cardioversion in patients with atrial fibrillation and atrial flutter Am J Cardiol 113 2014 1362 1363
-
(2014)
Am J Cardiol
, vol.113
, pp. 1362-1363
-
-
Yadlapati, A.1
Groh, C.2
Passman, R.3
-
4
-
-
70349306707
-
Dabigatran versus warfarin in patients with atrial fibrillation
-
S.J. Connolly, M.D. Ezekowitz, S. Yusuf, J. Eikelboom, J. Oldgren, A. Parekh, J. Pogue, P.A. Reilly, E. Themeles, J. Varrone, S. Wang, M. Alings, D. Xavier, J. Zhu, R. Diaz, B.S. Lewis, H. Darius, H.C. Diener, C.D. Joyner, L. Wallentin RE-LY Steering Committee and Investigators Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
-
(2009)
N Engl J Med
, vol.361
, pp. 1139-1151
-
-
Connolly, S.J.1
Ezekowitz, M.D.2
Yusuf, S.3
Eikelboom, J.4
Oldgren, J.5
Parekh, A.6
Pogue, J.7
Reilly, P.A.8
Themeles, E.9
Varrone, J.10
Wang, S.11
Alings, M.12
Xavier, D.13
Zhu, J.14
Diaz, R.15
Lewis, B.S.16
Darius, H.17
Diener, H.C.18
Joyner, C.D.19
Wallentin, L.20
more..
-
5
-
-
77953168824
-
Dabigatran etexilate - a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity
-
J. van Ryn, J. Stangier, S. Haertter, K.H. Liesenfeld, W. Wienen, M. Feuring, and A. Clemens Dabigatran etexilate - a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity Thromb Haemost 103 2010 1116 1127
-
(2010)
Thromb Haemost
, vol.103
, pp. 1116-1127
-
-
Van Ryn, J.1
Stangier, J.2
Haertter, S.3
Liesenfeld, K.H.4
Wienen, W.5
Feuring, M.6
Clemens, A.7
-
6
-
-
84856593171
-
Using the HEMOCLOT direct thrombin inhibitor assay to determine plasma concentrations of dabigatran
-
J. Stangier, and M. Feuring Using the HEMOCLOT direct thrombin inhibitor assay to determine plasma concentrations of dabigatran Blood Coagul Fibrinolysis 23 2012 138 143
-
(2012)
Blood Coagul Fibrinolysis
, vol.23
, pp. 138-143
-
-
Stangier, J.1
Feuring, M.2
-
7
-
-
41949116970
-
Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate
-
J. Stangier Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate Clin Pharmacokinet 47 2008 285 295
-
(2008)
Clin Pharmacokinet
, vol.47
, pp. 285-295
-
-
Stangier, J.1
-
8
-
-
84955632791
-
-
Accessed on December 22, 2014
-
Boehringer Ingelheim. Pradaxa product monograph. Available at: http://www.boehringer-ingelheim.ca/en/content/dam/internet/opu/ca-EN/documents/humanhealth/product-monograph/PradaxaPMEN.pdf. Accessed on December 22, 2014.
-
Pradaxa product monograph
-
-
Boehringer Ingelheim1
-
9
-
-
79953656178
-
Efficacy and safety of dabigatran vs. warfarin in patients with atrial fibrillation - sub-analysis in Japanese population in RE-LY trial
-
M. Hori, S.J. Connolly, M.D. Ezekowitz, P.A. Reilly, S. Yusuf, and L. Wallentin Efficacy and safety of dabigatran vs. warfarin in patients with atrial fibrillation - sub-analysis in Japanese population in RE-LY trial Circ J 75 2011 800 805
-
(2011)
Circ J
, vol.75
, pp. 800-805
-
-
Hori, M.1
Connolly, S.J.2
Ezekowitz, M.D.3
Reilly, P.A.4
Yusuf, S.5
Wallentin, L.6
-
10
-
-
33646470969
-
An overview of the structure and function of thrombin
-
E.W. Davie, and J.D. Kulman An overview of the structure and function of thrombin Semin Thromb Hemost 32 suppl 1 2006 3 15
-
(2006)
Semin Thromb Hemost
, vol.32
, pp. 3-15
-
-
Davie, E.W.1
Kulman, J.D.2
-
12
-
-
84875071896
-
Oral bioavailability of dabigatran etexilate (Pradaxa(®)) after co-medication with verapamil in healthy subjects
-
S. Hartter, R. Sennewald, G. Nehmiz, and P. Reilly Oral bioavailability of dabigatran etexilate (Pradaxa(®)) after co-medication with verapamil in healthy subjects Br J Clin Pharmacol 75 2013 1053 1062
-
(2013)
Br J Clin Pharmacol
, vol.75
, pp. 1053-1062
-
-
Hartter, S.1
Sennewald, R.2
Nehmiz, G.3
Reilly, P.4
|